市场调查报告书
商品编码
1497796
美容注射市场:按产品、性别、应用和最终用户 - 2024-2030 年全球预测Aesthetic Injectables Market by Product (Anti-aging Injections, Dermal Fillers), Gender (Female, Male), Application, End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年註射美容市场规模为110.8亿美元,预计2024年将达119.5亿美元,2030年将达188.1亿美元,复合年增长率为7.85%。
美容注射是非手术美容治疗,将肉毒桿菌毒素或皮肤填充剂等物质注射到皮肤中,以减少皱纹的出现,增强脸部轮廓,并恢復失去的体积。这些手术旨在提供更年轻的外观,无需进行侵入性手术,最大限度地减少停机时间,并提供更快、更少痛苦的替代方案。由于社群媒体和名人的影响,社会越来越重视外表和年轻,这推动了美容注射的需求。人们越来越注重自己的外表,并寻求治疗来保持年轻的外表。微创技术的进步使这些手术更安全、更有效、副作用更少、恢復时间更快。可支配收入的增加使更多人能够获得这些治疗,进一步推动了市场的扩张。使用美容注射可能会导致副作用和併发症,包括瘀伤和肿胀,从而阻碍市场成长。这些风险可能会阻止潜在客户。注射剂配方和技术的持续创新预计将透过提高治疗的功效和安全性以及改善结果并减少副作用来创造市场成长机会。
主要市场统计 | |
---|---|
基准年[2023] | 110.8亿美元 |
预测年份 [2024] | 119.5亿美元 |
预测年份 [2030] | 188.1亿美元 |
复合年增长率(%) | 7.85% |
区域洞察
由于高可支配收入、重视外表的趋势以及整容手术的广泛接受,以北美为中心的北美和南美注射美容市场保持强劲并持续增长。大量美容医生的存在、注射技术的不断进步以及强劲的消费者需求正在推动美洲市场的成长。由于人们对美容疗程的认识和接受度不断提高,南美洲正在呈现持续成长。由于可支配收入的增加、都市化以及对美容和个人护理有着浓厚兴趣的中阶的不断壮大,亚太地区(APAC)的美容注射市场正在迅速扩张。韩国、日本和中国等国家处于领先地位,其中韩国尤其被誉为先进的整容手术和非手术手术市场。重视年轻的文化以及社群媒体和名流文化的影响力是主要驱动力。此外,与西方国家相比,治疗成本相对较低,使得这些治疗更容易获得。欧洲、中东和非洲 (EMEA) 地区是美容注射的多元化市场。在高可支配收入、强大的医疗保健系统和广泛的社会接受度的推动下,英国、德国和法国等国家对非手术整容手术的需求很高,处于领先地位。中东潜力大,尤其是阿联酋和沙乌地阿拉伯,富人众多,对奢侈品和美容服务的需求旺盛。非洲仍然是一个新兴市场,市场成长主要集中在都市区,这些地区经济状况不断改善,美容意识不断增强。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在美容注射剂市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对美容注射市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在美容注射剂市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[187 Pages Report] The Aesthetic Injectables Market size was estimated at USD 11.08 billion in 2023 and expected to reach USD 11.95 billion in 2024, at a CAGR 7.85% to reach USD 18.81 billion by 2030.
Aesthetic injectables are non-surgical cosmetic treatments that involve injecting substances such as botulinum toxin and dermal fillers into the skin to decrease the appearance of wrinkles, enhance facial contours, and restore lost volume. These procedures are designed to provide a youthful appearance without the need for invasive surgery, offering a quicker, less painful alternative with minimal downtime. The heightened societal emphasis on physical appearance and youthfulness fueled by social media and the influence of celebrities is driving the demand for aesthetic injectables. People are more conscious of their looks and seek treatments that help them maintain a youthful appearance. Advancements in minimally invasive techniques have made these procedures safer and more effective, with fewer side effects and shorter recovery times. Rising disposable incomes, which have enabled more people to afford these treatments are boarding the scope of the market. The potential for side effects and complications, which can include bruising and swelling, with the use of aesthetic injectables hampers the market's growth. These risks can deter potential clients. Continuous innovation in injectable formulations and techniques enhances the efficacy and safety of treatments potentially reducing the side effects, and improving results are expected to create opportunities for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 11.08 billion |
Estimated Year [2024] | USD 11.95 billion |
Forecast Year [2030] | USD 18.81 billion |
CAGR (%) | 7.85% |
Regional Insights
The market for aesthetic injectables in the Americas, particularly North America, is robust and continues to grow due to high disposable incomes, a strong emphasis on physical appearance, and widespread acceptance of cosmetic procedures. The presence of a large number of aesthetic practitioners, continuous advancements in injectable technologies, and significant consumer demand drive the market growth in the Americas. South America is representing continuous growth, spurred by increasing awareness and acceptance of aesthetic treatments. In the Asia-Pacific (APAC) region, the aesthetic injectables market is expanding rapidly, fueled by rising disposable incomes, urbanization, and a growing middle class with a strong interest in beauty and personal care. Countries such as South Korea, Japan, and China are at the forefront, with South Korea particularly known for its advanced cosmetic surgery and non-surgical procedure market. The cultural emphasis on youthful appearances and the influence of social media and celebrity culture are significant drivers. Additionally, the relatively lower procedure cost than in Western countries makes these treatments more accessible. The Europe, Middle East, and Africa (EMEA) region presents a diverse market for aesthetic injectables. Countries such as the United Kingdom, Germany, and France lead with high demand for non-surgical cosmetic procedures, driven by high disposable incomes, strong healthcare systems, and widespread societal acceptance. The Middle East shows significant potential, particularly in affluent countries including the UAE and Saudi Arabia, with a strong demand for luxury and beauty services. In Africa, the market is still emerging, with growth primarily in urban centers where economic conditions are improving and awareness of aesthetic procedures is increasing.
Market Insights
The market dynamics represent an ever-changing landscape of the Aesthetic Injectables Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Aesthetic Injectables Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Aesthetic Injectables Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Cynosure and Lutronic Merge to Form Global Leader in Medical Aesthetic Technology
Cynosure and Hahn & Company, the recent acquirer of Lutronic, have announced their definitive agreement to merge Cynosure and Lutronic. Both companies are prominent energy-based medical aesthetic systems providers, and this merger creates a leading global medical aesthetics technology company. The combined entity features a diverse and innovative product portfolio, operational in over 130 countries. [Published On: 2024-01-20]
Galderma Launches FACE by Galderma, a New AR Tool Helps Visualize Injectable Treatment Results
Galderma has introduced FACE by Galderma, an augmented reality (AR) tool designed for aesthetic professionals and patients to visualize injectable treatment results before the procedure begins. This tool provides a simulated real-time "before and after" visual, helping to address patient concerns about the outcomes of injectable treatment. [Published On: 2023-03-22]
FDA Approves SKINVIVE by JUVEDERM, a new U.S. Hyaluronic Acid Injection for Smoother Cheeks
Allergan Aesthetics, an AbbVie company, has announced the U.S. FDA approval of SKINVIVE by JUVEDERM for enhancing skin smoothness in adults over 21. This product is the first and only hyaluronic acid (HA) intradermal microdroplet injection in the U.S., designed to improve skin quality in the cheeks. The injectable contains a small amount of lidocaine and provides hydration and smoothness, with results lasting up to six months and optimal treatment. [Published On: 2023-03-15]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Aesthetic Injectables Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Aesthetic Injectables Market, highlighting leading vendors and their innovative profiles. These include Adoderm GmbH, Allergan, Inc. by AbbVie Inc., Anika Therapeutics, Inc., Bio Plus Co., Ltd., Bioxis Pharmaceuticals, Bloomage Biotechnology Corp., Ltd., Bohus Biotech AB, Croma-Pharma GmbH, Cutera, Inc., Cynosure, LLC, Dr. Korman Laboratories Ltd., Galderma SA, Hugel America, Inc., Ipsen Pharma, Laboratoires Vivacy, S.A.S., MedyTox Inc., Merz Pharma GmbH & Co.KGaA, Prollenium Medical Technologies Inc., Revance Therapeutics, Inc., SciVision Biotech Inc., Sinclair Pharma Ltd, Suneva Medical, Inc., Teoxane SA, USWM, LLC, and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage
T